ClinicalTrials.Veeva

Menu

Preconditioning With Sevoflurane and Propofol in Patients Undergoing Minimally Invasive Mitral Valve Surgery (MINI-SEVO)

F

Fondazione Toscana Gabriele Monasterio

Status

Unknown

Conditions

Myocardial Ischemia

Treatments

Drug: sevofluorane

Study type

Observational

Funder types

Other

Identifiers

NCT02551328
452/2014

Details and patient eligibility

About

The main aim of this study is to compare markers of cardiac injury (Troponin I), inflammatory response and platelets function during minimally invasive mitral valve repair or replacement (MIMV) via right mini-thoracotomy in two standard anaesthetic regimes (sevo \propofol)

Full description

The main aim of this study is to compare markers of cardiac injury (Troponin I), inflammatory response and platelets function during minimally invasive mitral valve repair or replacement (MIMV) via right mini-thoracotomy in two standard anaesthetic regimes:

  • Volatile conditioning (sevoflurane) used during induction (preconditioning) and during the operation as maintenance (perconditioning) and no propofol.
  • Propofol induction and maintenance (TIVA) and no volatile anaesthetics.

Outlet/residual blood samples coming from routine check will be collected at different time points.

Study will be powered on Troponin I (primary statistical outcome). Original secondary outcome will be considered: platelets activation, left ventricle function, clinical figures (length of stay, inotrops requirements, ventilation times and other relevant).

Enrollment

48 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥18
  2. Patients undergoing elective (or urgent) first-time minimal invasive mitral valve surgery.

Exclusion criteria

  1. Cardiogenic shock or cardiac arrest, emergent CABG
  2. Renal failure (with a GFR < 30 ml/min/1.73m2),
  3. Glibenclamide or nicorandil (as these medications may interfere with VC)
  4. Pregnancy
  5. Known intolerance/allergy to sevoflurane or propofol

Trial design

48 participants in 2 patient groups

Sevofluorane
Description:
Patients preconditioned with Sevo
Treatment:
Drug: sevofluorane
Propofol
Description:
Patients with no preconditioning

Trial contacts and locations

1

Loading...

Central trial contact

Alessandra Parlanti, Pharmacist

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems